(Q46848816)

25 December 2017

title

Astrocyte-derived retinoic acid: a novel regulator of blood-brain barrier function in multiple sclerosis (English)

1 reference

25 December 2017

0 references

0 references

1 reference

1 reference

10

Helga E de Vries

1 reference

25 December 2017

author name string

Mark R Mizee

1

1 reference

25 December 2017

Philip G Nijland

2

1 reference

25 December 2017

Susanne M A van der Pol

3

1 reference

25 December 2017

Joost A R Drexhage

4

1 reference

25 December 2017

Bert van Het Hof

5

1 reference

25 December 2017

Reina Mebius

6

1 reference

25 December 2017

Paul van der Valk

7

1 reference

25 December 2017

Jack van Horssen

8

1 reference

25 December 2017

Arie Reijerkerk

9

1 reference

25 December 2017

publication date

23 August 2014

1 reference

25 December 2017

published in

Acta Neuropathologica

1 reference

25 December 2017

volume

128

1 reference

25 December 2017

issue

5

1 reference

25 December 2017

page(s)

691-703

1 reference

25 December 2017

https://scigraph.springernature.com/pub.10.1007/s00401-014-1335-6

exact match

0 references

cites work

Astrocyte-endothelial interactions at the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1335-6

The Hedgehog pathway promotes blood-brain barrier integrity and CNS immune quiescence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1335-6

Toll-like receptor 3 on adult human astrocytes triggers production of neuroprotective mediators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1335-6

Reactive gliosis and the multicellular response to CNS damage and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1335-6

Leukocyte infiltration, neuronal degeneration, and neurite outgrowth after ablation of scar-forming, reactive astrocytes in adult transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1335-6

Establishment of human adult astrocyte cultures derived from postmortem multiple sclerosis and control brain and spinal cord regions: immunophenotypical and functional characterization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1335-6

Retinoic acid synthesis and signaling during early organogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1335-6

Human monocyte isolation methods influence cytokine production from in vitro generated dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1335-6

IL-6-deficient mice resist myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1335-6

Loss of blood-brain barrier integrity in the spinal cord is common to experimental allergic encephalomyelitis in knockout mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1335-6

Reactive astrocytes protect tissue and preserve function after spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1335-6

NADPH oxidase expression in active multiple sclerosis lesions in relation to oxidative tissue damage and mitochondrial injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1335-6

SOX-18 controls endothelial-specific claudin-5 gene expression and barrier function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1335-6

Approach for defining endogenous reference genes in gene expression experiments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1335-6

The CCL2 synthesis inhibitor bindarit targets cells of the neurovascular unit, and suppresses experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1335-6

Gp130-dependent astrocytic survival is critical for the control of autoimmune central nervous system inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1335-6

IFN-γ signaling to astrocytes protects from autoimmune mediated neurological disability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1335-6

Retinoid X receptor gamma signaling accelerates CNS remyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1335-6

Retinoic acid receptor stimulation protects midbrain dopaminergic neurons from inflammatory degeneration via BDNF-mediated signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1335-6

A membrane receptor for retinol binding protein mediates cellular uptake of vitamin A

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1335-6

All-trans-retinoic acid rescues neurons after global ischemia by attenuating neuroinflammatory reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1335-6

Synthetic retinoid AM80 inhibits Th17 cells and ameliorates experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1335-6

Expression of retinoid X receptor β is induced in astrocytes during corpus callosum demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1335-6

Adenosine triphosphate-binding cassette transporters mediate chemokine (C-C motif) ligand 2 secretion from reactive astrocytes: relevance to multiple sclerosis pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1335-6

Astroglia-derived retinoic acid is a key factor in glia-induced neurogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1335-6

Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1335-6

The molecular basis of neurodegeneration in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1335-6

Progressive multiple sclerosis: pathology and pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1335-6

Retinol levels are associated with magnetic resonance imaging outcomes in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1335-6

Multiple sclerosis: recent developments in neuropathology, pathogenesis, magnetic resonance imaging studies and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1335-6

Classical immunomodulatory therapy in multiple sclerosis: how it acts, how it works

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1335-6

Blood-brain barrier disruption in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1335-6

Retinoic acid induces blood-brain barrier development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1335-6

Activation of antioxidant/electrophile-responsive elements in IMR-32 human neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1335-6

Astrocytes in multiple sclerosis: a product of their environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1335-6

Cell-selective knockout and 3D confocal image analysis reveals separate roles for astrocyte-and endothelial-derived CCL2 in neuroinflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1335-6

Diapedesis of monocytes is associated with MMP-mediated occludin disappearance in brain endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1335-6

Anti-alpha4 integrin therapy for multiple sclerosis: mechanisms and rationale.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1335-6

Natalizumab: bench to bedside and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1335-6

Side by side comparison between dynamic versus static models of blood-brain barrier in vitro: a permeability study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1335-6

Reactive oxygen species alter brain endothelial tight junction dynamics via RhoA, PI3 kinase, and PKB signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1335-6

Protective effects of peroxiredoxin-1 at the injured blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1335-6

Astrocytes as a regulated source of retinoic acid for the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1335-6

HIV-infection of the central nervous system: the tightrope walk of innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1335-6

Fingolimod attenuates ceramide-induced blood-brain barrier dysfunction in multiple sclerosis by targeting reactive astrocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1335-6

Radical changes in multiple sclerosis pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1335-6

Reactive astrocytes form scar-like perivascular barriers to leukocytes during adaptive immune inflammation of the CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1335-6

Multiple retinol and retinal dehydrogenases catalyze all-trans-retinoic acid biosynthesis in astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1335-6

Identification of retinoic acid as an inhibitor of transcription factor Nrf2 through activation of retinoic acid receptor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1335-6

Requirement for RAR-mediated gene repression in skeletal progenitor differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1335-6

Reduced expression of PGC-1α partly underlies mitochondrial changes and correlates with neuronal loss in multiple sclerosis cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1335-6

Retinoic acid receptor beta2 promotes functional regeneration of sensory axons in the spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1335-6

9-Cis-retinoic acid suppresses inflammatory responses of microglia and astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1335-6

Estrogen receptor and PI3K/Akt signaling pathway involvement in S-(-)equol-induced activation of Nrf2/ARE in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1335-6

Nrf2 promotes neuronal cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1335-6

Protective Role of Reactive Astrocytes in Brain Ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1335-6

Blood-brain barrier-specific properties of a human adult brain endothelial cell line

21 January 2018

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1096/FJ.04-3458FJE

Identifiers

DOI

10.1007/S00401-014-1335-6

1 reference

25 December 2017

1 reference

25 December 2017